Advertisement
Person › Details
Jeffrey P. McMullen (PharmaNet Development Group Inc.)
McMullen, Jeffrey P. (PharmaNet 201003 CEO)
![]() |
Organisation | PharmaNet Development Group Inc. |
| Group | PharmaNet (Group) | |
![]() |
Product | analytical services |
| Product 2 | drug development services | |
PharmaNet Development Group, Inc.. (3/1/10). "Press Release: George A. McMillan Joins PharmaNet Development Group as Chief Financial Officer". Princeton, NJ.
PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, announced today that George A. McMillan has joined the Company as Chief Financial Officer.
"We are pleased to have George join PharmaNet Development Group," commented Jeffrey P. McMullen, President and Chief Executive Officer. "He has proven experience in successfully driving financial management strategies and productivity improvement initiatives for both public and private organizations."
Mr. McMillan joins PharmaNet Development Group from Ze-Gen, Inc., a Boston-based renewable energy company, where he filled the dual role of Chief Operating Officer and Chief Financial Officer. Previously, George held the position of Chief Financial Officer, Chief Executive Officer, and Chief Operating Officer at diversified technology and services firms, including The Palladium Group, Inc., CMGI, Inc., BMG Direct (Bertelsmann A.G.), Renaissance Solutions, Eastern Exclusives and others.
Mr. McMillan has an A.B. in Economics from Stanford University and received his J.D. and M.B.A. from Harvard University.
About PharmaNet Development Group, Inc.
PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,300 employees and 41 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development. For more information, please visit our website at www.pharmanet.com.
Contact: Anne-Marie Hess
Phone: (609) 951-6842
Email: ahess@pharmanet.com
Record changed: 2011-11-25 |
More documents for Jeffrey P. McMullen
- [1] PharmaNet Development Group, Inc.. (5/17/11). "Press Release: inVentiv Health to Acquire PharmaNet. Creates a Top Global Contract Research Organization with Fully Integrated Development Capabilities". Burlington, MA....
- [2] PharmaNet Development Group, Inc.. (11/15/10). "Press Release: PharmaNet Launches New Brand Identity at Upcoming Industry Conferences". Princeton, NJ....
- [3] PharmaNet Development Group, Inc.. (7/19/10). "Press Release: Riaz Bandali Heads PharmaNet Development Group’s Early Stage Business". Princeton, NJ....
- [4] PharmaNet Development Group, Inc.. (3/1/10). "Press Release: George A. McMillan Joins PharmaNet Development Group as Chief Financial Officer". Princeton, NJ....
To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com
» top
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spectrometry-portal-logo.jpg)







![Banner [iiito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)